Infectious intracranial aneurysms are rare aneurysms that form in the arterial wall as a result of circulating infectious material, usually from foci of infection within the cardiac valves or endocardium. Some of the general symptoms of this disease are double vision, cranial nerve palsy, and localized headache.
Smoking, hypertension, genetic predisposition, and blood vessel damage are some of the factors that lead to cerebral disorders. According to the World Health Organization (WHO), over 1.13 billion people have experience hypertension worldwide. These factors will increase the risk of an intracranial aneurysm resulting in increased revenue growth of the market.
Hereditary control, atherosclerosis infection, sedentary lifestyle, high blood pressure, and brain injury are all major factors that cause this disease. As a result, the growing number of patients suffering from this condition is propelling the brain aneurysm treatment market forward. Furthermore, technical advances in the endovascular treatment of intracranial aneurysms are fueling the overall growth of the intracranial aneurysm market. The market is also being fueled by the increasing prevalence of target diseases in both developed and developing countries.
Key Market Trends Observed in Intracranial Aneurysm Market
Endovascular Coiling is expected to expand steadily in the future. This is a minimally invasive procedure that involves using a catheter to treat an intracranial aneurysm by stopping blood from entering arteries. The advantages of this technique, such as easier access to the vertebrobasilar system and multiple aneurysms in distant areas, as well as a shorter recovery time than other treatments, resulting in faster growth.
The growing number of strokes around the world would have a higher risk of rupturing blood vessels and causing an intracranial aneurysm, enhancing industry sales growth. The brain aneurysm treatment market has been fuelled by substantial advances in the last few years with volumes of supporting evidence, an increase in the use of advanced technology for the diagnosis and treatment of brain aneurysms, and the genetic factor responsible for the disease’s incidence.
North America to Hold a Significant Share in the Intracranial Aneurysm Market
Owing to the growing prevalence of intracranial aneurysms, increasing demand for minimally invasive procedures, and rising incidences of stroke, North America is projected to hold a large market share in the global intracranial aneurysm market. As per the study of Neuro Intervention India, a large section of the population in the United States have an unruptured intracranial aneurism, with the geriatric population being more susceptible. Additionally, increasing healthcare expenditure and the existence of well-established healthcare infrastructure are fueling the region’s overall growth.
Competitive Scenario of Intracranial Aneurysm Market
Companies use product releases and FDA approvals as a strategy to extend their global presence and meet increasing demand. This is the most common strategy used by market players to increase their product portfolio. The market players in the intracranial aneurysm t market use partnerships to expand their consumer base around the world, which also allows them to retain their brand identity globally. Some of the leading players in the market include Codman Neuro, MicroVention Inc., Microport Scientific Corporation, Stryker, MicroVention Inc., Johnson and Johnson Services Inc., and B. Braun.
Deep-dive Insights on Intracranial Aneurysm Market by Polaris Market Research: https://www.polarismarketresearch.com/industry-analysis/intracranial-aneurysm-market/request-for-sample